Prosecution Insights
Last updated: October 25, 2026

Siskinds LLP

Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems

7 pending office actions • 4 clients • 7 examiners • 7 art units • 0 of 7 (0%) have an AI response strategy ready

Analysis

This profile has 6 pending office actions in Biotechnology & Pharmaceuticals. Its career record includes 193 applications, with a resolved allowance rate of 89.13%. The current docket is limited relative to the historical application record.

The average is 2.73 office actions per allowance. Practitioners can use the allowance rate as a historical outcome reference and the office-action figure for planning prosecution interaction, while keeping current matters distinct from resolved applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=193 apps, methodology: how we score firms)

89.1%
Allowance Rate
n=193
+0.64σ
Allowance Rate (norm)
n=193
2.7
OAs to Allowance
n=123
-0.26σ
OAs to Allow (norm)
n=123
1002 days
Time to Allowance
n=123
-1.8pp
Interview Lift
n=193
20.3%
RCE Rate
n=193
0.7%
Appeal Rate
n=193

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=7 (min 20)
67.9%
§102 Overcome
n=56
74.4%
§103 Overcome
n=78
74.2%
§112 Overcome
n=66

Specialization & Scale

A61K, Y10T, B65G
Top CPC Subclasses
12%
Top-3 CPC Share
n=193
1
Practitioners
n=193
193.0
Apps / Practitioner
n=193

Portfolio Summary

7
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

6
Hard (86%)
1
Medium (14%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (14%)
§102 only1 (14%)
Multi-statute (no §101)5 (71%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
57% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
3
Mechanical / Eng
43% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WALTER, AUDREY BRADLEY 1 80.9% +23.9%
SHEPHERD, MATTHEW RICHARD 1 54.5% +39.7%
IANNUZO, NATALIE NMN 1 12.2% +71.4%
DEKARSKE, MADELINE MCGUIRE 1 20.0% +50.0%
CHIN, PAUL T 1 71.6% +15.7%
SHIAO, YIH-HORNG 1 72.6% +75.9%
ISMAIL, REHANA 1 76.2% +34.8%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18007982 CANNABINOID-HYALURONIC ACID BIOCONJUGATES SHIAO, YIH-HORNG 23d overdue
18073838 CLAMPING LINEAR ACTUATOR CHIN, PAUL T 16d overdue
18848610 SPORT PADDLE WALTER, AUDREY BRADLEY —
18572696 CANNABINOID-CONTAINING FORMULA FOR SKIN CARE IANNUZO, NATALIE NMN —
18560206 PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES DEKARSKE, MADELINE MCGUIRE —
18007935 RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF ISMAIL, REHANA —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18007982 CANNABINOID-HYALURONIC ACID BIOCONJUGATES SHIAO, YIH-HORNG 23d overdue
18073838 CLAMPING LINEAR ACTUATOR CHIN, PAUL T 16d overdue
18436712 ROLLER SHADE ASSEMBLY SHEPHERD, MATTHEW RICHARD 19d
18848610 SPORT PADDLE WALTER, AUDREY BRADLEY —
18572696 CANNABINOID-CONTAINING FORMULA FOR SKIN CARE IANNUZO, NATALIE NMN —
18560206 PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES DEKARSKE, MADELINE MCGUIRE —
18007935 RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF ISMAIL, REHANA —

Client Portfolio (4 clients)

Top Art Units

Art UnitApps
37111
36341
16531
16221
36541
16911
16251

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18848610 SPORT PADDLE 2 Pong Inc. WALTER, AUDREY BRADLEY 3711 §102§103 Non-Final OA — Pending Sep 19, 2024
18436712 ROLLER SHADE ASSEMBLY Smart Shade Innovations Inc. SHEPHERD, MATTHEW RICHARD 3634 §102 Final Rejection 19d Pending Feb 08, 2024
18572696 CANNABINOID-CONTAINING FORMULA FOR SKIN CARE London Pharmaceuticals And Research Corporation IANNUZO, NATALIE NMN 1653 §102§103§112 Non-Final OA — Pending Dec 20, 2023
18560206 PSILOCYBIN AND PSILOCIN CONJUGATES FOR TREATMENT OF MENTAL ILLNESSES London Pharmaceuticals And Research Corporation DEKARSKE, MADELINE MCGUIRE 1622 §103§112 Non-Final OA — Pending Nov 10, 2023
18073838 CLAMPING LINEAR ACTUATOR Ray Givens CHIN, PAUL T 3654 §102§112 Final Rejection 16d overdue Pending Dec 02, 2022
18007982 CANNABINOID-HYALURONIC ACID BIOCONJUGATES London Pharmaceuticals And Research Corporation SHIAO, YIH-HORNG 1691 §102§103§112 Final Rejection 23d overdue Pending Dec 02, 2022
18007935 RIGID CANNABIDIOL ANALOGUES AS POTENT MODULATORS OF CANNABINOID RECEPTORS AND USES THEREOF London Pharmaceuticals And Research Corporation ISMAIL, REHANA 1625 §101§102§112 Non-Final OA — Pending Dec 02, 2022

Managing Siskinds LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

What is Siskinds LLP's patent allowance rate?

89.1% of resolved applications prosecuted by Siskinds LLP were allowed, across 193 applications in USPTO records.

How many office actions does Siskinds LLP average before allowance?

2.73 office actions per allowed application on average.

How many pending office actions does Siskinds LLP have?

7 pending office actions as of October 2026, for 4 clients, before 7 examiners in 7 art units.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month